Introduction
The prevalence of
Clostridium difficile
infection is rapidly increasing worldwide, but prevalence is difficult to estimate in developing countries where awareness, diagnostic resources, and surveillance protocols are limited. As diarrhea is the hallmark symptom, we conducted a systematic review and meta-analysis to determine the prevalence and incidence of
C. difficile
infection in patients in these regions who presented with diarrhea.
Methods
We conducted a systematic literature search of MEDLINE/PubMed, Scopus, and Latin-American and Caribbean Health Sciences Literature databases to identify and analyze data from recent studies providing prevalence or incidence rates of
C. difficile
-associated diarrhea in developing countries within four regions: Africa–Middle East, developing Asia, Latin America, and China. Our objectives were to determine the current prevalence and incidence density rates of first episodes of
C. difficile
-associated diarrhea in developing countries.
Results
Within the regions included in our analysis, prevalence of
C. difficile
infection in patients with diarrhea was 15% (95% CI 13–17%) (including community and hospitalized patients), with no significant difference across regions. The incidence of
C. difficile
infection in 17 studies including this information was 8.5 per 10,000 patient-days (95% CI 5.83–12.46). Prevalence was significantly higher in hospitalized patients versus community patients (
p
= 0.0227).
Conclusion
Our prevalence estimate of 15% is concerning; however, low awareness and inconsistent diagnostic and surveillance protocols suggest this is markedly underestimated. Enhanced awareness and management of
C. difficile
infection in patients with diarrhea, along with improvements in infection control and surveillance practices, should be implemented to reduce prevalence of
C. difficile
-associated diarrhea in developing countries.
Funding
Pfizer Inc.
Electronic supplementary material
The online version of this article (10.1007/s40121-019-0231-8) contains supplementary material, which is available to authorized users.